Timing of safety-related labeling changes and marketing withdrawals for new molecular entities (1991-2007)

被引：0
|
作者：
McAdams, Mara A. [1 ]
Staffa, Judy A. [1 ]
Iyasu, Solomon [1 ]
Dal Pan, Gerald I. [1 ]
机构：
[1] US FDA, Off Surveillance & Epidemiol, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
467
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 13 条
  • [1] The Use of Social Media in Detecting Drug Safety-Related New Black Box Warnings, Labeling Changes, or Withdrawals: Scoping Review
    Lee, Jae-Young
    Lee, Yae-Seul
    Kim, Dong Hyun
    Lee, Han Sol
    Yang, Bo Ram
    Kim, Myeong Gyu
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2021, 7 (06):
  • [2] Decision and timing of safety-related labeling changes for new drugs in Japan: Comparison with the United States and the European Union
    Fukuda, Koichi
    Narukawa, Mamoru
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (12) : 1331 - 1340
  • [3] Safety-related drug labeling changes in the United States and Germany
    Garbe, Edeltraut
    Schade, Rene
    Andersohn, Frank
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S13 - S13
  • [4] Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration
    Croteau, David
    Pinnow, Ellen
    Wu, Eileen
    Munoz, Monica
    Bulatao, Ilynn
    Dal Pan, Gerald
    DRUG SAFETY, 2022, 45 (02) : 169 - 180
  • [5] Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration
    David Croteau
    Ellen Pinnow
    Eileen Wu
    Monica Muñoz
    Ilynn Bulatao
    Gerald Dal Pan
    Drug Safety, 2022, 45 : 169 - 180
  • [6] Changes in Occupational Safety and Health Indices After the Korean Economic Crisis: Analysis of a National Sample, 1991-2007
    Min, Kyoung-Bok
    Min, Jin-Young
    Park, Jae-Beom
    Park, Shin-Goo
    Lee, Kyung-Jong
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 100 (11) : 2165 - 2167
  • [7] A Comparison of Safety-Related Label Changes for Medicines With and Without Major Objections at Time of Marketing Authorisation
    Bloem, L.
    Karomi, M.
    Hoekman, J.
    Leufkens, H.
    Klungel, O.
    Mantel-Teeuwisse, A.
    DRUG SAFETY, 2018, 41 (11) : 1167 - 1168
  • [8] Postmarketing Safety-Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002-2014: Similarities and Differences With New Molecular Entities
    Bulatao, Ilynn
    Pinnow, Ellen
    Day, Brendan
    Cherkaoui, Sanae
    Kalaria, Manish
    Brajovic, Sonja
    Dal Pan, Gerald
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1243 - 1253
  • [9] A comparison of decision and timing of safety related labeling changes for new drugs approved both in Japan and the United States
    Hoshino, Yuko
    Narukawa, Mamoru
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (05) : 561 - 572
  • [10] Trends and Subgroup Differences in Transportation-Related Injury Risk and Safety Behaviors Among US High School Students, 1991-2007
    Jones, Sherry E.
    Shults, Ruth A.
    JOURNAL OF SCHOOL HEALTH, 2009, 79 (04) : 169 - 176
12